Literature DB >> 28973259

New simple radiological criteria proposed for multiple primary lung cancers.

Takeshi Matsunaga1, Kenji Suzuki1, Kazuya Takamochi1, Shiaki Oh1.   

Abstract

BACKGROUND: Controversies remain as to the differential diagnosis between multiple primary lung cancer (MPLC) and intrapulmonary metastasis (IM) in lung cancers. We have investigated the clinical criteria for MPLC and here propose a set of new and simple criteria from the stand point of prognosis.
METHODS: A retrospective study was conducted on 588 consecutive patients with resected lung cancer of clinical Stage IA between 2009 and 2012. Multiple lung cancers (MLCs) were observed in 103 (17.5%) of the 588 patients. All main and other tumors were divided into solid tumor (ST) and non-solid tumor (non-ST). We defined Group A as MLCs having at least one non-ST and Group B as all tumors being ST. Cox's proportional hazard model was used for the multivariate analyses to investigate the preoperative prognostic factors. We divided the MLCs into MPLC and IM based on the preoperative prognostic factors, and survival was estimated by the Kaplan-Meier method.
RESULTS: A multivariate analysis with Cox's proportional hazards model revealed that Group A independently predicted good overall survival (HR = 0.165, 95% CI: 0.041-0.672).Differences in the 3- and 5-year overall survivals between Groups A and B were statistically significant (96.3%/92.2% vs. 70.0%/60.0%, Pvalue = 0.0002).
CONCLUSIONS: We suggest that Group A, defined as the presence of at least one tumor with a ground glass opacity component and clinical N0, should be excluded from the conventional concept of multiple lung cancers based on the criteria of Martini and Melamed as it has a very good prognosis. This group would be considered to be radiological MPLC.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  lung cancer; multiple primary lung cancer; pulmonary metastasis; pulmonary resection

Mesh:

Year:  2017        PMID: 28973259     DOI: 10.1093/jjco/hyx113

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  [Research Progress in Distinguishing Methods of Simultaneous Multiple Primary Lung Cancer and Intrapulmonary Metastasis].

Authors:  Jifan Wang; Te Zhang; Hanlin Ding; Gaochao Dong; Lin Xu; Feng Jiang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-05-20

2.  Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.

Authors:  Ping-Chung Tsai; Chia Liu; Yi-Chen Yeh; Chun-Ku Chen; Po-Kuei Hsu; Hui-Shan Chen; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

3.  Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer.

Authors:  Qianqian Zhao; Gang Chen; Luxi Ye; Zhaochong Zeng; Shiming Shi; Jian He
Journal:  Cancer Manag Res       Date:  2018-11-28       Impact factor: 3.989

4.  Clinical features and outcomes of patients with stage I multiple primary lung cancers.

Authors:  Yasushi Shintani; Jiro Okami; Hiroyuki Ito; Takashi Ohtsuka; Shinichi Toyooka; Takeshi Mori; Shun-Ichi Watanabe; Hisao Asamura; Masayuki Chida; Hiroshi Date; Shunsuke Endo; Takeshi Nagayasu; Ryoichi Nakanishi; Etsuo Miyaoka; Meinoshin Okumura; Ichiro Yoshino
Journal:  Cancer Sci       Date:  2021-03-09       Impact factor: 6.716

5.  Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?

Authors:  Rirong Qu; Dehao Tu; Wei Ping; Ni Zhang; Xiangning Fu
Journal:  Onco Targets Ther       Date:  2021-02-16       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.